logo-loader
HealthPharma & Biotech
Supreme Pharmaceuticals

Supreme Pharma raises C$3.6mln for greenhouse expansion

The completion of phase 1 is projected to increase total production capacity to over 10,000 kilograms per year,

Picture of cannabis plant
Money will add 80,000 sq ft to greenhouse

Supreme Pharmaceuticals Inc (CSE:SL) has raised C$3.62mln from a share and a warrant issue to expand its Kincardine greenhouse facility after strong demand recently for its medical-use marijuana.

John Fowler, Supreme’s chief executive, said: "One month ago, we secured supply agreements with five Canadian medical marijuana licensed producers for substantially all of the expected output of phase 0 of our seven-acre hybrid greenhouse.

“Given the strong demand, we will begin phase 1 expansion of an additional 80,000 square feet of hybrid greenhouse area.

“The completion of phase 1 is projected to increase total production capacity to over 10,000 kilograms per year, subject to regulatory approval."

At that point the company may consider a second tranche of financing, said Fowler.

Quick facts: Supreme Pharmaceuticals

Price: £0.00

Market: CSE
Market Cap: £0.00
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

1 day, 18 hours ago

2 min read